Genetics and genomics are increasingly important in disease prevention, surveillance and population-health planning. This session explores genomic epidemiology, genetic screening, precision public health, pathogen genomics, molecular surveillance and the ethical, legal and social implications of genomic technologies.
Submissions may address genetic risk, population screening, genomic data, pathogen sequencing, precision prevention, policy and ethics. Geneticists, laboratory scientists, epidemiologists, clinicians, bioinformaticians, researchers, public-health professionals and policymakers are invited to participate.






Title : Eliminating implant failure in humans with nanomaterials: 30,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Adoption of Personalized and Precision Medicine (PPM)-guided resources in addressing national biosafety: A green light towards innovations to secure individualized, population, regional and planetary health through personalized nutrition and precision foodomics
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation